CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Swept Source Optical Coherence Tomography Angiographyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05082402
NCT05082402N/ACompleted
CompareCT.gov

Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease

Northwestern University·observational·Posted Oct 19, 2021·Updated May 22, 2026

In Brief

An observational study evaluating Swept Source Optical Coherence Tomography Angiography for Cardiovascular Diseases and Retina; Change. Completed, enrolled 42 participants across 1 site.

Detailed Summary

This study aims to determine whether changes in retinal vasculature seen on SS-OCTA can be correlated to degree of cardiovascular disease as measured by carotid duplex ultrasonography.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Retina; Change
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 19, 2021
Enrollment StartAug 17, 2021
Primary CompletionOct 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 4.7 years ago

Interventions

Swept Source Optical Coherence Tomography Angiographyother

The PLEX Elite 9000 is an FDA cleared research device for use in ocular imaging obtained by Northwestern University by way of a purchase agreement with the manufacturer, Carl Zeiss Meditec, Inc. It is currently unavailable outside of participation in the ARI Network, a cloudbased storage and image processing platform using deidentified information shared between academic institutions. The ARI Network is managed by a group of physicians and scientists from around the world that are working to better understand eye diseases.